Loading...
Quantum-Si incorporated
QSI•NASDAQ
Healthcare
Biotechnology
$2.14
$0.16(8.08%)
Quantum-Si incorporated (QSI) Financial Performance & Statements
Review Quantum-Si incorporated’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
182.62%
↑ 182.62%
Operating Income Growth
2.33%
↑ 2.33%
Net Income Growth
-5.26%
↓ 5.26%
Operating Cash Flow Growth
6.64%
↑ 6.64%
Operating Margin
-3204.41%
↓ 3204.41%
Gross Margin
52.77%
↑ 52.77%
Net Profit Margin
-2925.41%
↓ 2925.41%
ROE
-44.46%
↓ 44.46%
ROIC
-42.65%
↓ 42.65%
Quantum-Si incorporated (QSI) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Quantum-Si incorporated stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $842000.00 | $1.19M | $787000.00 | $622000.00 |
| Cost of Revenue | $356000.00 | $582000.00 | $420000.00 | $268000.00 |
| Gross Profit | $486000.00 | $610000.00 | $367000.00 | $354000.00 |
| Gross Profit Ratio | $0.58 | $0.51 | $0.47 | $0.57 |
| R&D Expenses | $13.72M | $16.99M | $16.17M | $14.38M |
| SG&A Expenses | $11.88M | $14.30M | $12.28M | $12.42M |
| Operating Expenses | $25.60M | $31.29M | $28.45M | $26.80M |
| Total Costs & Expenses | $25.95M | $31.87M | $28.88M | $27.07M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $994000.00 | $1.16M | $1.39M |
| EBITDA | -$25.11M | -$29.68M | -$26.93M | -$25.06M |
| EBITDA Ratio | -$29.82 | -$24.90 | -$34.22 | -$40.30 |
| Operating Income | -$25.11M | -$30.68M | -$28.09M | -$26.45M |
| Operating Income Ratio | -$29.82 | -$25.74 | -$35.69 | -$42.53 |
| Other Income/Expenses (Net) | $5.93M | -$2.43M | $2.82M | $3.35M |
| Income Before Tax | -$19.18M | -$33.11M | -$25.27M | -$23.10M |
| Income Before Tax Ratio | -$22.78 | -$27.78 | -$32.11 | -$37.14 |
| Income Tax Expense | -$11000.00 | $13000.00 | $43000.00 | $0.00 |
| Net Income | -$19.19M | -$33.12M | -$25.31M | -$23.10M |
| Net Income Ratio | -$22.79 | -$27.79 | -$32.16 | -$37.14 |
| EPS | -$0.11 | -$0.23 | -$0.18 | -$0.16 |
| Diluted EPS | -$0.11 | -$0.23 | -$0.18 | -$0.16 |
| Weighted Avg Shares Outstanding | $182.30M | $146.33M | $142.40M | $141.94M |
| Weighted Avg Shares Outstanding (Diluted) | $182.30M | $146.33M | $142.40M | $141.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan